Advances in Glutathione Research for Disease Research Targeted therapy for GSH metabolism has become a research hotspot, and metabolomics and proteomics technologies have also provided powerful tools for GSH-related research: Targeting GSH metabolism : Inhibiting key molecules such as GCLC, xCT (cysteine uptake carrier) or SLC25A39 (mitochondrial GSH transporter), or using GSH-depleting nanozymes, has shown the potential to enhance ROS-mediated tumor cell death and improve related disease symptoms in preclinical models (such as cell models and animal models), providing new strategies for disease treatment
Neuronal excitation upregulates Tbr1, a high-confidence risk gene of autism, mediating Grin2b expression in the adult brain
The technical term are fibrovascular lesions, since some nodules are comprised of both scar (fibro) and abnormal blood vessels (vascular) Depending on their size, vocal cord nodules can cause a raspy or breathy speaking voice
Reactive oxygen species-dependent c-Jun NH2-terminal kinase/c-Jun signaling cascade mediates neuroblastoma cell death induced by diallyl disulfide
Inhibicin de la melanina: convierte la eumelanina (pigmento oscuro) en feomelanina (pigmento claro), lo que da como resultado un aclaramiento y una luminosidad visibles de la piel
